Incidental Mutation 'R3743:Ccr7'
ID |
270461 |
Institutional Source |
Beutler Lab
|
Gene Symbol |
Ccr7
|
Ensembl Gene |
ENSMUSG00000037944 |
Gene Name |
C-C motif chemokine receptor 7 |
Synonyms |
EBI1, CD197, Cmkbr7, Ebi1h |
MMRRC Submission |
040729-MU
|
Accession Numbers |
|
Essential gene? |
Possibly non essential
(E-score: 0.314)
|
Stock # |
R3743 (G1)
|
Quality Score |
225 |
Status
|
Validated
|
Chromosome |
11 |
Chromosomal Location |
99035025-99045903 bp(-) (GRCm39) |
Type of Mutation |
missense |
DNA Base Change (assembly) |
G to T
at 99036033 bp (GRCm39)
|
Zygosity |
Heterozygous |
Amino Acid Change |
Serine to Arginine
at position 296
(S296R)
|
Ref Sequence |
ENSEMBL: ENSMUSP00000099423
(fasta)
|
Gene Model |
predicted gene model for transcript(s):
[ENSMUST00000103134]
|
AlphaFold |
P47774 |
Predicted Effect |
possibly damaging
Transcript: ENSMUST00000103134
AA Change: S296R
PolyPhen 2
Score 0.861 (Sensitivity: 0.83; Specificity: 0.93)
|
SMART Domains |
Protein: ENSMUSP00000099423 Gene: ENSMUSG00000037944 AA Change: S296R
Domain | Start | End | E-Value | Type |
signal peptide
|
1 |
24 |
N/A |
INTRINSIC |
Pfam:7tm_1
|
75 |
326 |
1.8e-49 |
PFAM |
|
Meta Mutation Damage Score |
0.2064 |
Coding Region Coverage |
- 1x: 99.2%
- 3x: 98.6%
- 10x: 97.2%
- 20x: 95.0%
|
Validation Efficiency |
98% (43/44) |
MGI Phenotype |
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor. Signals mediated by this receptor regulate T cell homeostasis in lymph nodes, and may also function in the activation and polarization of T cells, and in chronic inflammation pathogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Sep 2014] PHENOTYPE: Homozygous mice exhibit an impaired primary immune response. Dendritic cells, B, T and T regulatory cells show impaired migration to the lymph nodes and secondary lymph organs exhibit morphological abnormalities. Lymphocytic infiltrates to the pancreas, lung and stomach are observed in aged mice. [provided by MGI curators]
|
Allele List at MGI |
|
Other mutations in this stock |
Total: 44 list
Gene | Ref | Var | Chr/Loc | Mutation | Predicted Effect | Zygosity |
1700013G24Rik |
A |
G |
4: 137,182,348 (GRCm39) |
R168G |
probably damaging |
Het |
1700030K09Rik |
A |
G |
8: 73,199,013 (GRCm39) |
H140R |
probably benign |
Het |
Adamts10 |
A |
G |
17: 33,747,686 (GRCm39) |
I41V |
probably damaging |
Het |
Arnt |
T |
C |
3: 95,382,016 (GRCm39) |
V198A |
possibly damaging |
Het |
Atg3 |
A |
G |
16: 44,998,591 (GRCm39) |
|
probably null |
Het |
Atmin |
T |
C |
8: 117,683,312 (GRCm39) |
V324A |
probably benign |
Het |
Ccdc88c |
G |
A |
12: 100,914,843 (GRCm39) |
R464C |
probably damaging |
Het |
Cdh12 |
T |
A |
15: 21,537,745 (GRCm39) |
S415R |
probably damaging |
Het |
Cep162 |
A |
T |
9: 87,099,230 (GRCm39) |
|
probably benign |
Het |
Chd3 |
G |
A |
11: 69,254,876 (GRCm39) |
R61* |
probably null |
Het |
Cr2 |
A |
G |
1: 194,832,274 (GRCm39) |
|
probably benign |
Het |
Csf1r |
T |
C |
18: 61,247,846 (GRCm39) |
S305P |
probably benign |
Het |
Cyp4a31 |
A |
C |
4: 115,423,716 (GRCm39) |
Q140P |
possibly damaging |
Het |
Dhx40 |
A |
T |
11: 86,661,985 (GRCm39) |
W691R |
probably damaging |
Het |
Dlgap1 |
G |
A |
17: 71,025,221 (GRCm39) |
|
probably null |
Het |
Entr1 |
A |
G |
2: 26,278,655 (GRCm39) |
|
probably benign |
Het |
Exoc5 |
T |
C |
14: 49,251,806 (GRCm39) |
I582V |
probably benign |
Het |
Exoc5 |
A |
T |
14: 49,270,864 (GRCm39) |
L387* |
probably null |
Het |
Fbxw8 |
A |
G |
5: 118,251,704 (GRCm39) |
S270P |
probably damaging |
Het |
Fgf14 |
C |
A |
14: 124,914,032 (GRCm39) |
G33V |
probably benign |
Het |
Hoxd9 |
T |
A |
2: 74,528,710 (GRCm39) |
V104E |
probably damaging |
Het |
Igsf10 |
T |
C |
3: 59,233,546 (GRCm39) |
H1729R |
possibly damaging |
Het |
Irf8 |
C |
T |
8: 121,480,310 (GRCm39) |
R274C |
probably damaging |
Het |
Itgb4 |
G |
A |
11: 115,894,496 (GRCm39) |
M1350I |
probably damaging |
Het |
Lrrn4 |
A |
G |
2: 132,711,786 (GRCm39) |
|
probably null |
Het |
Map3k6 |
C |
T |
4: 132,972,384 (GRCm39) |
T320I |
probably benign |
Het |
Morc2a |
A |
G |
11: 3,633,700 (GRCm39) |
E604G |
possibly damaging |
Het |
Mtmr6 |
T |
C |
14: 60,537,747 (GRCm39) |
I582T |
probably benign |
Het |
Ninl |
A |
G |
2: 150,792,168 (GRCm39) |
V785A |
probably benign |
Het |
Obscn |
T |
C |
11: 58,969,911 (GRCm39) |
E77G |
probably damaging |
Het |
Or2b11 |
T |
C |
11: 59,462,335 (GRCm39) |
Y77C |
probably damaging |
Het |
Or2n1 |
T |
G |
17: 38,486,793 (GRCm39) |
F273V |
probably damaging |
Het |
Or4f61 |
A |
G |
2: 111,922,965 (GRCm39) |
L27P |
probably benign |
Het |
Pcdhb2 |
A |
G |
18: 37,429,470 (GRCm39) |
D124G |
probably damaging |
Het |
Pfkl |
G |
A |
10: 77,832,179 (GRCm39) |
T304M |
probably damaging |
Het |
Ppil4 |
T |
A |
10: 7,696,935 (GRCm39) |
S483T |
unknown |
Het |
Slc7a10 |
C |
T |
7: 34,898,325 (GRCm39) |
T332I |
probably damaging |
Het |
Spats2 |
T |
C |
15: 99,108,795 (GRCm39) |
S382P |
probably benign |
Het |
Stpg1 |
T |
A |
4: 135,242,197 (GRCm39) |
D70E |
probably benign |
Het |
Tmprss11e |
G |
A |
5: 86,857,315 (GRCm39) |
Q333* |
probably null |
Het |
Trpv1 |
A |
T |
11: 73,145,128 (GRCm39) |
D430V |
probably damaging |
Het |
Ttc23l |
G |
A |
15: 10,537,652 (GRCm39) |
S206L |
probably benign |
Het |
Ttc23l |
CT |
CTTGGATT |
15: 10,537,648 (GRCm39) |
|
probably benign |
Het |
Zc3h6 |
A |
G |
2: 128,839,712 (GRCm39) |
Y175C |
probably damaging |
Het |
|
Other mutations in Ccr7 |
Allele | Source | Chr | Coord | Type | Predicted Effect | PPH Score |
IGL01600:Ccr7
|
APN |
11 |
99,035,971 (GRCm39) |
missense |
probably benign |
0.45 |
Kongtong
|
UTSW |
11 |
99,036,489 (GRCm39) |
missense |
probably damaging |
1.00 |
lanzhou
|
UTSW |
11 |
99,036,103 (GRCm39) |
missense |
possibly damaging |
0.90 |
qinghai
|
UTSW |
11 |
99,036,649 (GRCm39) |
missense |
probably damaging |
1.00 |
IGL03047:Ccr7
|
UTSW |
11 |
99,036,160 (GRCm39) |
missense |
probably benign |
0.44 |
R0707:Ccr7
|
UTSW |
11 |
99,036,809 (GRCm39) |
missense |
probably damaging |
1.00 |
R1115:Ccr7
|
UTSW |
11 |
99,036,103 (GRCm39) |
missense |
possibly damaging |
0.90 |
R1664:Ccr7
|
UTSW |
11 |
99,036,517 (GRCm39) |
missense |
possibly damaging |
0.90 |
R2291:Ccr7
|
UTSW |
11 |
99,036,161 (GRCm39) |
missense |
probably damaging |
1.00 |
R4108:Ccr7
|
UTSW |
11 |
99,036,204 (GRCm39) |
missense |
probably damaging |
1.00 |
R4214:Ccr7
|
UTSW |
11 |
99,035,872 (GRCm39) |
missense |
probably damaging |
0.98 |
R5402:Ccr7
|
UTSW |
11 |
99,036,560 (GRCm39) |
missense |
possibly damaging |
0.93 |
R5602:Ccr7
|
UTSW |
11 |
99,036,315 (GRCm39) |
missense |
probably benign |
0.08 |
R6275:Ccr7
|
UTSW |
11 |
99,036,489 (GRCm39) |
missense |
probably damaging |
1.00 |
R6991:Ccr7
|
UTSW |
11 |
99,036,130 (GRCm39) |
missense |
probably damaging |
1.00 |
R7470:Ccr7
|
UTSW |
11 |
99,036,383 (GRCm39) |
missense |
possibly damaging |
0.80 |
R7549:Ccr7
|
UTSW |
11 |
99,036,727 (GRCm39) |
missense |
probably damaging |
1.00 |
R8973:Ccr7
|
UTSW |
11 |
99,036,649 (GRCm39) |
missense |
probably damaging |
1.00 |
R9117:Ccr7
|
UTSW |
11 |
99,036,086 (GRCm39) |
missense |
probably damaging |
1.00 |
R9206:Ccr7
|
UTSW |
11 |
99,039,895 (GRCm39) |
missense |
probably benign |
|
R9631:Ccr7
|
UTSW |
11 |
99,036,616 (GRCm39) |
missense |
probably benign |
0.01 |
Z1176:Ccr7
|
UTSW |
11 |
99,035,806 (GRCm39) |
missense |
probably damaging |
1.00 |
|
Predicted Primers |
PCR Primer
(F):5'- ACCACATTAAGGCTCCTGGG -3'
(R):5'- CTGGCTATGAGTTTCTGCTACC -3'
Sequencing Primer
(F):5'- CATTAAGGCTCCTGGGAGAGGTC -3'
(R):5'- GAGTTTCTGCTACCTCATTATCATC -3'
|
Posted On |
2015-03-18 |